Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis-Reference-Cited by-同舟云学术

Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis

Published:2008-05 Issue:5 Volume:42 Page:841-847
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Rizzoli René,Burlet Nansa,Cahall David,Delmas Pierre D.,Eriksen Erik Fink,Felsenberg Dieter,Grbic John,Jontell Mats,Landesberg Regina,Laslop Andrea,Wollenhaupt Martina,Papapoulos Socrates,Sezer Orhan,Sprafka Michael,Reginster Jean-Yves

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference60 articles.

1. Oral and maxillofacial pathology: a rationale for treatment,2002

2. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations.;American Dental Association Council on Scientific Affairs;J Am Dent Assoc,2006

3. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management;Ruggiero;Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2006

4. Position paper on bisphosphonate-related osteonecrosis of the jaws,2006

5. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research;Khosla;J Bone Miner Res,2007

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxyresveratrol attenuates bone resorption by inhibiting the mitogen-activated protein kinase pathway in ovariectomized rats;Nutrition & Metabolism;2024-01-19

2. Osteoporosis and Vertebral Column;Indian Journal of Orthopaedics;2023-11-17

3. A summary of the Malaysian Clinical Practice Guidelines on the management of postmenopausal osteoporosis, 2022;Osteoporosis and Sarcopenia;2023-06

4. Combined and sequential therapies with anabolic and antiresorptive drugs in the management of patients with postmenopausal osteoporosis;International Journal of Bone Fragility;2023-06-01

5. Approach to the Patient: Pharmacological Therapies for Fracture Risk Reduction in Adults With Osteogenesis Imperfecta;The Journal of Clinical Endocrinology & Metabolism;2023-01-20